QUINAZOLINE
(CID
9210
) -
BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(
2
)
Unspecified(1)
BioAssay Types:
Literature(
3
)
BioActivity Types:
IC50(
2
)
SAR
Target summary
Data download
Chemical Probe
Active
Inactive
Inconclusive
Unspecified
Total Bioassays: 3 Data Row: 3 Total Pages: 1
Sort:
[Click the result table header to sort]
#
Substance
Activity
BioAssay
Target
Links
Outcome
Type
Value [μM]
1
[SID
103238931
]
Active
IC50
0.0023
Inhibition of NADH fumarate reductase in Echinococcus multilocularis protoscolece [AID
422946
, Type: Literature]
View
X
Row No.
1
Structure
Substance
SID
103238931
CID
9210
Outcome
Active
IC50
0.0023 [uM]
BioAssay
Inhibition of NADH fumarate reductase in Echinococcus multilocularis protoscolece
AID
422946
BioAssay type
Literature
Target
PubMed
17954696
Data Table
2
[SID
103238931
]
Active
IC50
0.027
Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells [AID
69425
, Type: Literature]
View
X
Row No.
2
Structure
Substance
SID
103238931
CID
9210
Outcome
Active
IC50
0.027 [uM]
BioAssay
Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells
AID
69425
BioAssay type
Literature
Target
PubMed
8627606
Data Table
3
[SID
103238931
]
Unspecified
The concentration required to inhibit dihydrofolate reductase in rat liver [AID
58159
, Type: Literature]
View
X
Row No.
3
Structure
Substance
SID
103238931
CID
9210
Outcome
Unspecified
BioAssay
The concentration required to inhibit dihydrofolate reductase in rat liver
AID
58159
BioAssay type
Literature
Target
PubMed
6737433
Data Table
Chemical Probe 
Active 
Inactive 
Inconclusive 
Unspecified 
